Literature DB >> 538803

The Rift Valley fever epizootic in Egypt 1977-78. 1. Description of the epizzotic and virological studies.

J M Meegan.   

Abstract

From October to December 1977, an extensive epizootic occurred in Egypt resulting in abortions and increased mortality in domestic animals, and severe clinical disease with fatalities in man. Rift Valley Fever (RVF) virus was isolated and identified as the causative agent. In humans, acute febrile, encephalitic, ocular and fatal haemorrhagic diseases were documented as resulting from RVF virus infection. A retrospective serological survey indicated RVF was recently introduced into the area. The 1977 epizootic extensively involved five Governorates. In the summer and autumn of 1978, epizootic RVF reappeared in Egypt and spread to previously uninfected areas. Virological, serological and epidemiological studies, and factors related to the spread of RVF are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 538803     DOI: 10.1016/0035-9203(79)90004-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  107 in total

1.  Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein.

Authors:  Sonja R Gerrard; Stuart T Nichol
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Ngari virus is a Bunyamwera virus reassortant that can be associated with large outbreaks of hemorrhagic fever in Africa.

Authors:  Sonja R Gerrard; Li Li; Alan D Barrett; Stuart T Nichol
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

3.  Cloning and characterization of two glutathione S-transferases from pyrethroid-resistant Culex pipiens.

Authors:  Aman I Samra; Shizuo G Kamita; Hong-Wei Yao; Anthony J Cornel; Bruce D Hammock
Journal:  Pest Manag Sci       Date:  2012-01-30       Impact factor: 4.845

4.  Identification of Rift Valley fever virus nucleocapsid protein-RNA binding inhibitors using a high-throughput screening assay.

Authors:  Mary Ellenbecker; Jean-Marc Lanchy; J Stephen Lodmell
Journal:  J Biomol Screen       Date:  2012-05-29

5.  Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats.

Authors:  Aaron W Walters; Michael R Kujawa; Joseph R Albe; Douglas S Reed; William B Klimstra; Amy L Hartman
Journal:  Virology       Date:  2018-11-02       Impact factor: 3.616

6.  Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus.

Authors:  K Keegan; M S Collett
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

7.  Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strains.

Authors:  Nandadeva Lokugamage; Alexander N Freiberg; John C Morrill; Tetsuro Ikegami
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

8.  A statistical model of Rift Valley fever activity in Egypt.

Authors:  John M Drake; Ali N Hassan; John C Beier
Journal:  J Vector Ecol       Date:  2013-12       Impact factor: 1.671

9.  The first serological evidence for Rift Valley fever infection in the camel, goitered gazelle and Anatolian water buffaloes in Turkey.

Authors:  Sibel Gür; Mehmet Kale; Nural Erol; Orhan Yapici; Nuri Mamak; Sibel Yavru
Journal:  Trop Anim Health Prod       Date:  2017-08-31       Impact factor: 1.559

10.  Transcript Assembly and Quantification by RNA-Seq Reveals Significant Differences in Gene Expression and Genetic Variants in Mosquitoes of the Culex pipiens (Diptera: Culicidae) Complex.

Authors:  David S Kang; Sungshil Kim; Michael A Cotten; Cheolho Sim
Journal:  J Med Entomol       Date:  2021-01-12       Impact factor: 2.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.